Synergic production of neutrophil chemotactic activity by colonic epithelial cells and eosinophils

Immunobiology

Volumn 219, Issue 10, 2014, Pages 793-797

  Dent, Gordon ^a   Loweth, Sam C ^a   Hasan, Anwar Matar ^a   Leslie, Fiona M ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Chemoattractants; Chemokines; Eosinophils; Epithelium; Neutrophils

Indexed keywords

CHEMOATTRACTANT; CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; ZYMOSAN; CXCL1 PROTEIN, HUMAN; CXCL5 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ARTICLE; CELL INTERACTION; CELL STIMULATION; COCULTURE; COLON MUCOSA; COLONIC EPITHELIAL CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MYELOID LEUKEMIA CELL LINE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; CELL CULTURE; CELL LINE; CHEMOTAXIS; COLON; CYTOLOGY; EPITHELIUM CELL; PHYSIOLOGY; SECRETION (PROCESS); TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOKINE CXCL5; CHEMOTAXIS; COCULTURE TECHNIQUES; COLON; EOSINOPHILS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; NEUTROPHILS; ZYMOSAN;

EID: 84906791934     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.06.008     Document Type: Article

References (36)

1. Baumann M.A., Paul C.C. The AML14 and AML14.3D10 cell lines: long overdue model for the study of eosinophils and more. Stem Cells 1998, 16:16-24.
2. Baumgart D.C., McVay L.D., Carding S.R. Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease. Int. J. Mol. Med. 1998, 1:315-332.
3. Dent G., Giembycz M.A., Evans P.M., Rabe K.F., Barnes P.J. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptors agonist albuterol. J. Pharmacol. Exp. Ther. 1994, 271:1167-1174.
4. Dent G., Muñoz N.M., Rühlmann E., Zhu X., Leff A.R., Magnussen H., Rabe K.F. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils. Am. J. Respir. Cell Mol. Biol. 1998, 18:136-144.
5. 4 production by N-acetylcysteine: role of hydrogen peroxide. Br. J. Pharmacol. 1997, 122:758-764.
6. 4 generation through contact with bronchial epithelial cells. Inflamm. Res. 2000, 49:236-239.
7. Forbes E., Murase T., Yang M., Matthaei K.I., Lee J.J., Lee N.A., Foster P.S., Hogan S.P. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J. Immunol. 2004, 172:5664-5675.
8. Frank D.N., St.Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13780-13785.
9. Furuta G.T., Nieuwenhuis E.S., Karhausen J., Gleich G., Blumberg R.S., Lee J.J., Ackerman S.J. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G890-G897.
10. Hunyadi J., Simon M.Jr.Kenderessy A.S., Dobozy A. Expression of complement receptor CR2 (CD21) on human subcorneal keratinocytes in normal and diseased skin. Dermatologica 1991, 183:184-186.
11. Jawien J., Chlopicki S., Olszanecki R., Lorkowska B., Gryglewski R.J. Eosinophil-epithelial interaction augments cysteinyl leukotrienes synthesis. J. Physiol. Pharmacol. 2002, 53:127-132.
12. Kim Y.J., Kim E.H., Hahm K.B. Oxidative stress in inflammation-based gastrointestinal tract diseases. J. Gastroenterol. Hepatol. 2012, 27:1004-1010.
13. Lampinen M., Carlson M., Håkansson L.D., Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004, 59:793-805.
14. Langeggen H., Berge K.E., Johnson E., Hetland G. Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro. Inflammation 2002, 26:103-110.
15. Langeggen H., Namork E., Johnson E., Hetland G. HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro. FEMS Immunol. Med. Microbiol. 2003, 36:55-61.
16. Lebeis S.L., Sherman M.A., Kalman D. Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens. Future Microbiol. 2008, 3:315-328.
17. Lightfoot A.P., Hasan A.M., Dent G. Opsonized zymosan stimulates CXC chemokine secretion from bronchial epithelial cells. Eur. Respir. J. 2006, 28:229s.
18. Marsal J., Agace W.W. Targeting T-cell migration in inflammatory bowel disease. J. Intern. Med. 2012, 272:411-429.
19. Mishra R.K., Scaife J.E., Harb Z., Gray B.C., Djukanovic R., Dent G. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 2005, 60:1204-1207.
20. Motulsky H.J. Intuitive Biostatistics 2012, Oxford University Press, Oxford. 2nd ed.
21. Naito J., Takagi T., Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J. Clin. Biochem. Nutr. 2007, 41:18-26.
22. Nishitani H., Okabayashi M., Satomi M., Shimoyama T., Dohi Y. Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis. J. Gastroenterol. 1998, 33:189-195.
23. Ordás I., Eckmann L., Talamini M., Baumgart D.C., Sandborn W.J. Ulcerative colitis. Lancet 2012, 380:1606-1619.
24. Raab Y., Fredens K., Gerdin B., Hällgren R. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig. Dis. Sci. 1998, 43:1061-1070.
25. Resnick M.B., Colgan S.P., Patapoff T.W., Mrsny R.J., Awtrey C.S., Delp-Archer C., Weller P.F., Madara J.L. Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5'-AMP. J. Immunol. 1993, 151:5716-5723.
26. Rothenberg M., Mishra A., Brandt E., Hogan S.P. Gastrointestinal eosinophils in health and disease. Adv. Immunol. 2001, 78:291-328.
27. Saitoh O., Kojima K., Sugi K., Matsuse R., Uchida K., Tabata K., Nakagawa K., Kayazawa M., Hirata I. Fecal eosinophil granule-derived proteins reflect disease severity in inflammatory bowel disease. Am. J. Gastroenterol. 1999, 94:3513-3520.
28. Sasaki M., Klapproth J.M.A. The role of bacteria in the pathogenesis of ulcerative colitis. J. Signal Transduct. 2012, 10.1155/2012/704953.
29. Spoelstra F.M., Hovenga H., Noordhoek J.A., Postma D.S., Kauffman H.F. Changes in CD11b and l-selectin expression on eosinophils are mediated by human lung fibroblasts in vitro. Am. J. Respir. Crit. Care Med. 1998, 158:769-777.
30. Takizawa H., Sato M., Ito K. The interactions of eosinophils with bronchial epithelial cells in asthma. ACI Int. 1997, 9:149-155.
31. Taylor M.L., Dastych J., Sehgal D., Sundstrom M., Nilsson G., Akin C., Mage R.G., Metcalfe D.D. The kit-activating mutation D816V enhances stem cell factor-dependent chemotaxis. Blood 2001, 98:1195-1199.
32. Vainer B., Nielsen O.H., Horn T. Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), β2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease. Am. J. Surg. Pathol. 2000, 24:1115-1124.
33. Wedemeyer J., Vosskuhl K. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Best Pract. Res. Clin. Gastroenterol. 2008, 22:537-549.
34. Wolf H.M., Mannhalter J.W., Salzmann H.C., Göttlicher J., Ahmad R., Eibl M.M. Phagocytosis of serum-opsonized zymosan down-regulates the expression of CR3 and FcRI in the membrane of human monocytes. J. Immunol. 1988, 141:3537-3543.
35. Wong C.K., Wang C.B., Ip W.K., Tian Y.P., Lam C.W. Role of p38 MAPK and NF-κB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin. Exp. Immunol. 2005, 139:90-100.
36. Zhang S., Mohammed Q., Burbidge A., Morland C.M., Roche W.R. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro. Eur. Respir. J. 1996, 9:1839-1846.